Aigen Investment Management LP bought a new stake in Novanta Inc. (NASDAQ:NOVT - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 7,396 shares of the technology company's stock, valued at approximately $946,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Parallel Advisors LLC lifted its position in Novanta by 1,426.7% during the first quarter. Parallel Advisors LLC now owns 229 shares of the technology company's stock worth $29,000 after buying an additional 214 shares in the last quarter. Johnson Financial Group Inc. lifted its position in Novanta by 482.1% during the fourth quarter. Johnson Financial Group Inc. now owns 326 shares of the technology company's stock worth $49,000 after buying an additional 270 shares in the last quarter. GAMMA Investing LLC lifted its position in Novanta by 146.0% during the first quarter. GAMMA Investing LLC now owns 401 shares of the technology company's stock worth $51,000 after buying an additional 238 shares in the last quarter. CWM LLC lifted its position in Novanta by 329.8% during the first quarter. CWM LLC now owns 404 shares of the technology company's stock worth $52,000 after buying an additional 310 shares in the last quarter. Finally, Signaturefd LLC lifted its position in Novanta by 80.0% during the first quarter. Signaturefd LLC now owns 414 shares of the technology company's stock worth $53,000 after buying an additional 184 shares in the last quarter. Hedge funds and other institutional investors own 98.35% of the company's stock.
Novanta Trading Down 1.5%
Shares of NASDAQ NOVT traded down $1.76 during trading on Friday, reaching $116.42. The stock had a trading volume of 132,158 shares, compared to its average volume of 288,047. Novanta Inc. has a fifty-two week low of $98.76 and a fifty-two week high of $186.75. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.62 and a current ratio of 2.54. The business's 50-day moving average price is $124.99 and its 200-day moving average price is $128.38. The company has a market cap of $4.19 billion, a P/E ratio of 68.52 and a beta of 1.48.
Novanta (NASDAQ:NOVT - Get Free Report) last released its earnings results on Tuesday, August 5th. The technology company reported $0.76 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.74 by $0.02. The firm had revenue of $241.05 million during the quarter, compared to analyst estimates of $237.97 million. Novanta had a return on equity of 14.70% and a net margin of 6.41%. Novanta's revenue was up 2.2% compared to the same quarter last year. During the same period last year, the business posted $0.73 earnings per share. On average, equities research analysts predict that Novanta Inc. will post 3.03 EPS for the current fiscal year.
Analyst Ratings Changes
NOVT has been the subject of several recent analyst reports. Robert W. Baird cut their target price on Novanta from $139.00 to $133.00 and set a "neutral" rating for the company in a research note on Monday. Wall Street Zen cut Novanta from a "buy" rating to a "hold" rating in a research note on Monday.
View Our Latest Stock Report on NOVT
Novanta Company Profile
(
Free Report)
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Articles

Before you consider Novanta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.
While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.